AURA · Aura Biosciences, Inc.
$7.00
-0.04 (-0.50%)
At close · Jul 29
Going-concern doubt
— cleared May 11, 2026
The latest filing states the doubt was alleviated.
“As disclosed in the Company's audited consolidated financial statements as of and for the year ended December 31, 2025, events and conditions existed which raised substantial doubt about the Company's ability to continue as a going concern, primarily due to recurring operating losses, negative cash flows from operations and liquidity constraints. Subsequent to year end, the Company completed the 2026 Follow-On Offering, raising approximately $241.8 million in net proceeds after completion of the Matrix Repurchase. Based on the successful execution of this financing, management has concluded that the events and conditions that previously raised substantial doubt have been alleviated.”View the 10-Q filed May 11, 2026
Market Cap
$717.50M
Shares
103.39M
Options Calculator
Theoretical estimateEstimate what a long-dated option on AURA could return if you hold it and the stock reaches a target price. Premiums are theoretical Black-Scholes-Merton values — tune the inputs to match your broker, then compare each strike's return against simply holding the shares.
Best strike
—
Highest estimated return
Return at target
—
— annualized
Breakeven
—
Stock price to break even
Hold the stock
—
— annualized, with dividends
Return by strike at your target price
Strike ladder
| Strike | Moneyness | Premium | Breakeven | Value at target | Return | Annualized | Max loss |
|---|
Per share; one contract = 100 shares. Premiums are theoretical Black-Scholes-Merton estimates — real options are American-style and priced off an implied-volatility smile, so use your broker's quote for the actual premium. Not investment advice.
Loading strategy simulator…
Key facts
CIK
1501796
CUSIP
05153U107
13F (30d)
18 filings
18 filers
Visit website
Investor relations